Devyser (private company)

See something wrong or missing? Let us know
Offices:Stockholm
Business model:B2B

Devyser develops diagnostic kits for complex DNA testing within oncology, reproductive health and hereditary diseases.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 1.69M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Devyser

Name Criteria
Sweden Monocl
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: Gerhard Dal
Sweden Antrad
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one angel investor: Gerhard Dal
  • Total raised in a similar range: 1M - 5M USD
Sweden LipUm
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one angel investor: Gerhard Dal
  • Total raised in a similar range: 1M - 5M USD
Sweden Lytics
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one angel investor: Gerhard Dal
  • Total raised in a similar range: 1M - 5M USD
France AbolerIS Pharma
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Norway APIM Therapeutics
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Spain AptaTargets
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Athera
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden AttgeNO
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Denmark Biograil
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Top